The current control method for contagious bovine pleuropneumonia (CBPP) in Africa is vaccination with a live, attenuated strain of Mycoplasma mycoides subsp. mycoides (Mmm). However, this method is not very efficient and often causes serious adverse reactions. Several studies have attempted to induce protection using inactivated mycoplasma, but with widely contradictory results. Therefore, we compared the protective capacity of the live T1/44 vaccine with two inactivated preparations of Mmm strain Afadé, inoculated with an adjuvant. Protection was measured after a challenge with Afadé. The protection levels were 31%, 80.8% and 74.1% for the formalin-inactivated, heat-inactivated and live attenuated preparations, respectively. These findings indicate that low doses of heat-inactivated Mmm can offer protection to a level similar to the current live attenuated (T1/44) vaccine formulation.
Experimental evaluation of inactivated and live attenuated vaccines against Mycoplasma mycoides subsp. mycoides.
M. Mwirigi,I. Nkando,R. Aye,R. Soi,H. Ochanda,E. Berberov,A. Potter,V. Gerdts,J. Perez-Casal,J. Naessens,H. Wesonga
Published 2016 in Veterinary Immunology and Immunopathology
ABSTRACT
PUBLICATION RECORD
- Publication year
2016
- Venue
Veterinary Immunology and Immunopathology
- Publication date
Unknown publication date
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-22 of 22 references · Page 1 of 1
CITED BY
Showing 1-16 of 16 citing papers · Page 1 of 1